Lewicki John A.
SEC insider (Form 3/4/5 filer). CIK 0001553352. Chief Scientific Officer at Mereo BioPharma Group plc (MREO). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 1, 2026. Located in LONDON, X0.
Companies Lewicki John A. has filed insider reports for
- Mereo BioPharma Group plc (MREO): Officer, Chief Scientific Officer
Lewicki John A.
CIK: 0001553352
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mereo BioPharma Group plc
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Feb 1, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
139.9K shares- - Feb 1, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
46.6K shares- - Feb 1, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
145K shares- - Jan 25, 2025MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
116K shares- - Sep 13, 2024MREO
Mereo BioPharma Group plc
SaleDirect10.9K shares at avg. $4.22$46K - Sep 12, 2024MREO
Mereo BioPharma Group plc
SaleDirect5.2K shares at avg. $4.47$23K - Sep 11, 2024MREO
Mereo BioPharma Group plc
ExerciseDirect46K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 139,913 | - | - | Direct |
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 46,637 | - | - | Direct |
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 145,000 | - | - | Direct |
| Jan 25, 2025 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 116,000 | - | - | Direct |
| Sep 13, 2024 | MREO Mereo BioPharma Group plc | Sale | 10,937 | $4.22 | $46,165 | Direct |
| Sep 12, 2024 | MREO Mereo BioPharma Group plc | Sale | 5,212 | $4.47 | $23,312 | Direct |
| Sep 11, 2024 | MREO Mereo BioPharma Group plc | Exercise | 46,000 | - | $0 | Direct |
1-7 of 7 transactions